Sinopharm Group Co. Ltd. financial statements, including revenue, expenses, profit, and loss
The total revenue of SHTDF for the last semiannual is 40.89 B USD, and it's 5.83% lower compared to the previous semiannual. The net income of H2 23 is 684.57 M USD.